These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9564622)

  • 1. The oxidation of dopamine and epinine by the two forms of monoamine oxidase from rat liver.
    Strolin Benedetti M; Sanson G; Bona L; Gallina M; Persiani S; Tipton KF
    J Neural Transm Suppl; 1998; 52():233-8. PubMed ID: 9564622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ; King J; Kotzuk J; Schoepp DD; Frost J; Schochet S
    J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.
    O'Carroll AM; Fowler CJ; Phillips JP; Tobbia I; Tipton KF
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):198-202. PubMed ID: 6408492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
    Waldmeier PC; Delini-Stula A; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):9-14. PubMed ID: 934359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain.
    Ross SB
    J Neurochem; 1987 Feb; 48(2):609-14. PubMed ID: 3098921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some factors influencing the metabolism of benzylamine by type A and B monoamine oxidase in rat heart and liver.
    Parkinson D; Lyles GA; Browne BJ; Callingham BA
    J Pharm Pharmacol; 1980 Dec; 32(12):844-50. PubMed ID: 6110749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of different amine oxidases to the metabolism of dopamine in bovine retina.
    Fernández de Arriba A; Lizcano JM; Balsa D; Unzeta M
    Biochem Pharmacol; 1991 Nov; 42(12):2355-61. PubMed ID: 1764119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex.
    Guimarães JT; Vindis C; Soares-da-Silva P; Parini A
    Life Sci; 2003 Jul; 73(8):955-67. PubMed ID: 12818349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phe(208) and Ile(199) in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat.
    Geha RM; Chen K; Shih JC
    J Neurochem; 2000 Sep; 75(3):1304-9. PubMed ID: 10936214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues.
    Yu PH; Bailey BA; Durden DA; Boulton AA
    Biochem Pharmacol; 1986 Mar; 35(6):1027-36. PubMed ID: 3954792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity.
    Grimsby J; Zentner M; Shih JC
    Life Sci; 1996; 58(9):777-87. PubMed ID: 8632725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC; Soares-da-Silva P
    Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties).
    Gesi M; Santinami A; Ruffoli R; Conti G; Fornai F
    Pharmacol Toxicol; 2001 Nov; 89(5):217-24. PubMed ID: 11881974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.